INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 446m ago
HOUSE PTR46m ago
SEC 13F46m ago
ROBINHOOD CHAIN46m ago
Public company

OMEROS CORP

OMERCIK 0001285819

EDGAR filingsOpen in network
Price$16.92
1 year+142.1%
Disclosed transactions0
Buys / sells0 / 0
Max Insider Score—
Connections with evidence4

OMER · disclosed activity on price

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Lobbied forevidence
    AQUIA GROUP, LLCLDA 1TY 2026 first quarter · issues not listed · Aug 26, 2026
  • ← Lobbied forevidence
    THE NICKLES GROUP, LLCLDA Q2 2026 second quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    THE PETRIZZO GROUP, INC.LDA RA 2026 third quarter · Health issues, MED · Aug 26, 2026

Lobbying

$0 reported · de-duplicated
2026 Q3 $0 via firms2026 Q2 $0 via firms2026 Q1 $0 via firms
  • AQUIA GROUP, LLC—2026 Q1 · posted Aug 26, 2026 ·
  • THE NICKLES GROUP, LLC—2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
  • THE NICKLES GROUP, LLC—2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
  • THE PETRIZZO GROUP, INC.—2026 Q3 · posted Aug 26, 2026 · Health issues, MED

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.